BioCentury
ARTICLE | Product Development

Digital health: payers are figuring out what it’s worth

Back to School 2019: The first payer models for digital therapeutics are coming into view next year

August 31, 2019 5:28 AM UTC

Payers are starting to sort out how to reimburse for digital therapies and tools while they get up to speed on the new class of products. The answer is more of an “it depends” than a straight “no,” as they wait for answers on how trial results translate to measurable benefits.

The big questions are what level of evidence payers will need to see and what the ROI is to the system...